Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Cell-Free DNA Screening vs Direct Invasive Diagnosis on Miscarriage Rates in Women With Pregnancies at High Risk of Trisomy 21: A Randomized Clinical Trial.
Malan V, Bussières L, Winer N, Jais JP, Baptiste A, Le Lorc'h M, Elie C, O'Gorman N, Fries N, Houfflin-Debarge V, Sentilhes L, Vekemans M, Ville Y, Salomon LJ; SAFE 21 Study Group. Malan V, et al. Among authors: bussieres l. JAMA. 2018 Aug 14;320(6):557-565. doi: 10.1001/jama.2018.9396. JAMA. 2018. PMID: 30120476 Free PMC article. Clinical Trial.
[Cell-free fetal DNA screening tests for trisomy 21].
Malan V, Bussières L, Salomon LJ. Malan V, et al. Among authors: bussieres l. Gynecol Obstet Fertil. 2016 Dec;44(12):675-678. doi: 10.1016/j.gyobfe.2016.10.002. Epub 2016 Nov 7. Gynecol Obstet Fertil. 2016. PMID: 27839716 Review. French. No abstract available.
Assessment of human placental perfusion by intravoxel incoherent motion MR imaging.
Siauve N, Hayot PH, Deloison B, Chalouhi GE, Alison M, Balvay D, Bussières L, Clément O, Salomon LJ. Siauve N, et al. Among authors: bussieres l. J Matern Fetal Neonatal Med. 2019 Jan;32(2):293-300. doi: 10.1080/14767058.2017.1378334. Epub 2017 Oct 3. J Matern Fetal Neonatal Med. 2019. PMID: 28974131 Clinical Trial.
Non-invasive prenatal testing for trisomy 21 based on analysis of cell-free fetal DNA circulating in the maternal plasma.
Alberti A, Salomon LJ, Le Lorc'h M, Couloux A, Bussières L, Goupil S, Malan V, Pelletier E, Hyon C, Vialard F, Rozenberg P, Bouhanna P, Oury JF, Schmitz T, Romana S, Weissenbach J, Vekemans M, Ville Y. Alberti A, et al. Among authors: bussieres l. Prenat Diagn. 2015 May;35(5):471-6. doi: 10.1002/pd.4561. Prenat Diagn. 2015. PMID: 25643828
92 results